Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from RBC Capital

RBC Capital Cuts Price Target On This REIT By 4%

RBC Capital analyst Jimmy Shan has reduced the Canadian Apartment Properties REIT (TSX:CAR) (OTC:CDPYF) price target to C$66 from C$69. The analyst maintained the Outperform rating on the shares. Shan remarked that 1Q22 reflected a difficult winter but an increasing revenue forecast, which the second half should better reflect. Given the current valuation, NCIB…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

What Are Whales Doing With Palantir Technologies

Someone with a lot of money to spend has taken a bearish stance on Palantir Technologies (NYSE:PLTR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Vale Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Vale. Looking at options history for Vale (NYSE:VALE) we detected 11 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022

Upgrades

Benzinga

RBC Capital Slashes Cascades Price Target By 12%

Cascades Inc. (TSX:CAS) (OTC:CADNF) price target has been lowered to C$15 from C$17 by RBC Capital analyst Paul C. Quinn after the Q1 results. The analyst maintained the Outperform rating on the shares. Quinn mentions that the company reported 1Q22 Adjusted EBITDA of $58 million, which was well below their $89 million forecast and consensus…

Benzinga

RBC Capital Cuts Softchoice Price Target By 15%

RBC Capital analyst Paul Treiber lowered the price target for Softchoice Corp (TSX:SFTC) (OTC:SFTFC) to C$23 from C$27 while maintaining the Sector Perform rating on the shares, given reduced peer valuations. The analyst states that Softchoice reported Q1 below consensus/RBC, as certain onetime headwinds weighed on profitability and growth. Positively, Software & Cloud revenue was…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Ahead Of Upcoming Data On Three Programs, Analysts Remain On Sidelines For Wave Life Sciences

RBC Capital writes that Wave Life Sciences Ltd's (NASDAQ: WVE) Q1 earnings are largely incremental.

Benzinga

RBC Capital Cuts iA Financial Price Target By ~10%

iA Financial Corporation Inc (TSX:IAG) (OTC:IAFNF) price target has been reduced to C$86 from C$96 by RBC Capital analyst Darko Mihelic to account for higher risk in the current environment. The analyst maintained the Outperform rating on the shares. Mihelic mentioned that analysts have significantly reduced the 2022 core EPS estimate following the quarter, but…

Benzinga

What's Going On With CCL Industries Shares Today

RBC Capital analyst Walter Spracklin lowered the price target for CCL Industries Inc (TSX:CCL) (OTC:CCDBF) to C$74 from C$80. The analyst maintained the Outperform rating on the shares. Spracklin states that 1Q22 results came in above expectations and (in contrast with last quarter) there was no cautionary language around near term trends. The company indicated…

Benzinga

Why Boat Rocker Media Shares Are Trading Higher Today

Boat Rocker Media Inc (TSX: BRMI) price target has been lowered to C$9 from C$10 by RBC Capital analyst Drew McReynolds while maintaining the Outperform rating in the shares. 1Q22 results were below the analyst firm's forecast attributed entirely to timing given the inherent quarterly volatility of the business.

Benzinga

RBC Capital Cuts Stella-Jones Price Target By 7%

Stella-Jones Inc (TSX:SJ) (OTC:STLJF) price target has been lowered to C$40 from C$43 by RBC Capital analyst Walter Spracklin. The analyst maintained the Sector Perform rating on the shares. Spracklin stated that SJ started the year strong, with Q1 results ahead of expectations and a better than expected top-line across all segments. However, the company…

Benzinga

RBC Capital Cuts Equitable Group Price Target By ~6%

RBC Capital analyst Geoffrey Kwan lowered the price target for Equitable Group Inc. (TSX: EQB) (OTC: EQGPF) to C$80 from C$85. The analyst maintained the Outperform rating on the shares.

Benzinga

RBC Capital Maintains Sector Perform Rating for Fiverr International: Here's What You Need To Know

RBC Capital has decided to maintain its Sector Perform rating of Fiverr International (NYSE:FVRR) and lower its price target from $80.00 to $32.00. Shares of Fiverr International are trading up 11.48% over the last 24 hours, at $33.88 per share.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

RBC Capital Cuts Hudbay Minerals Price Target By 14%

RBC Capital analyst Sam Crittenden lowered the price target for HudBay Minerals Inc (TSX:HBM) (NYSE:HBM) to C$12 from C$14. The analyst maintained the Outperform rating on the shares. Crittenden stated that, despite what should be the year's weakest quarter, he continues to expect strong FCF and production growth from Hudbay in 2022. The analyst believes…

Benzinga

What's Going On With Keyera Shares Today

Keyera Corp (TSX:KEY) (OTC:KEYUF) price target was raised to C$37 from C$35 by RBC Capital analyst Robert Kwan. The risk-adjusted expected total return to price target supports Outperform rating for the shares. With the recent Investor Day in March, the analyst viewed most of the quarterly updates as incremental, although noted the increase in guidance…

Benzinga

RBC Capital Trims Melcor Developments Price Target By 5%

Melcor Developments Ltd. (TSX:MRD) (OTC:MODVF) price target has been lowered to C$18 from C$19 by RBC Capital analyst Tom Callaghan. The analyst maintained the Sector Perform rating on the shares. Callaghan states that there is no change in constructive stance on Melcor Developments following Q1 results. The analyst continues to see several tailwinds in both…

Benzinga

RBC Capital Bumps Up Suncor Energy Price Target By 12%

RBC Capital analyst Greg Pardy raised the price target for Suncor Energy Inc. (TSX:SU) (NYSE:SU) to C$47 from C$42 while maintaining the Sector Perform rating on the shares. The analyst states that Suncor’s Q1 results were solid while its conference call was uneventful. Pardy mentions that Suncor’s operating performance path will determine its relative market…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

RBC Capital Cuts dentalcorp Price Target By 10%

dentalcorp Holdings Ltd (TSX: DNTL) price target has been lowered to C$18 from C$20 by RBC Capital analyst Douglas Miehm. The analyst has an Outperform rating on the shares.

Benzinga

RBC Capital Maintains Sector Perform Rating for Angi: Here's What You Need To Know

RBC Capital has decided to maintain its Sector Perform rating of Angi (NASDAQ:ANGI) and lower its price target from $7.00 to $6.00. Shares of Angi are trading up 3.08% over the last 24 hours, at $4.53 per share. A move to $6.00 would account for a 32.6% increase from the…

Benzinga

RBC Capital Bumps Up George Weston Price Target By ~8%

RBC Capital analyst Irene Nattel raised the price target for George Weston Ltd (TSX:WN) (OTC:WNGRF) to C$179 from C$165 with an Outperform rating on the shares. The analyst updated the model and valuation to reflect the actual Q1 share buyback at George Weston along with Q1 results. Nattel says that the constructive outlook on George Weston…

Benzinga

RBC Capital Boosts Ensign Energy Services Price Target By 8%

Ensign Energy Services Inc (TSX:ESI) (OTC:ESVIF) price target has been raised to C$6.50 from C$6 by RBC Capital analyst Keith Mackey. The analyst maintained the Outperform, Speculative Risk rating on the shares. Mackey stated that Ensign's 1Q22 results were in line with estimates, and the company modestly improved its financial liquidity through the disposition of…

Benzinga

What Are Whales Doing With Palantir Technologies

Benzinga

RBC Capital Maintains Outperform Rating for ADC Therapeutics: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of ADC Therapeutics (NYSE:ADCT) and lower its price target from $34.00 to $30.00. Shares of ADC Therapeutics are trading down 1.34% over the last 24 hours, at $7.71 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

1 … 5 6 7 8

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.